Aarey Drugs Pharmaceuticals Ltd vs Bafna Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 15, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 78.9 as of 12 Jun 15:30 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 8.3 on March 2021 to 23.9 on March 2025 . This represents a CAGR of 23.56% over 5 yearsThe P/E Ratio of Bafna Pharmaceuticals Ltd changed from 55.8 on March 2021 to 42.6 on March 2025 . This represents a CAGR of -5.26% over 5 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 54.25 crore on March 2021 to ₹ 95.58 crore on March 2025 . This represents a CAGR of 11.99% over 5 yearsThe Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 324.8 crore on March 2021 to ₹ 177.42 crore on March 2025 . This represents a CAGR of -11.39% over 5 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 189.04 crore as compare to the Dec '25 revenue of ₹ 100.61 crore. This represent the growth of 87.89% The revenue of Bafna Pharmaceuticals Ltd for the Mar '26 is ₹ 44 crore as compare to the Dec '25 revenue of ₹ 39.51 crore. This represent the growth of 11.36% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 3.91 crore as compare to the Dec '25 ebitda of ₹ 2.67 crore. This represent the growth of 46.44% The ebitda of Bafna Pharmaceuticals Ltd for the Mar '26 is ₹ 5.31 crore as compare to the Dec '25 ebitda of ₹ 4.27 crore. This represent the growth of 24.36% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 1.24 crore to ₹ 1.56 crore over 8 quarters. This represents a CAGR of 12.16% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ -0.72 crore to ₹ 2.75 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Bafna Pharmaceuticals Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 223 Cr while Market cap of Bafna Pharmaceuticals Ltd is 393 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd?

As of June 15, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹78.9. On the other hand, Bafna Pharmaceuticals Ltd stock price is INR ₹166.25.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Bafna Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.